← Open Payments lookup

KATHRYN PENN: Open Payments

NPI 1295011377 · LAUREL, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$321 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $321

Food & beverage: $321
CompanyPaymentsAmount
Lilly USA, LLC3$67
Novo Nordisk Inc3$60
Xeris Pharmaceuticals, Inc.2$36
ABBVIE INC.1$34
Lundbeck LLC2$33
PFIZER INC.2$33
Inspire Medical Systems, Inc.1$30
Amgen Inc.1$14
Abbott Laboratories1$14

Products named: Ozempic, MOUNJARO, GVOKE HYPOPEN, QULIPTA, VYEPTI, PREVNAR 20, INSPIRE, ZEPBOUND.

Industry payments across MD — which companies pay providers there.